loadpatents
Patent applications and USPTO patent grants for Thompson; Christopher F..The latest application filed is for "cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors".
Patent | Date |
---|---|
Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors Grant 10,059,705 - Dinsmore , et al. August 28, 2 | 2018-08-28 |
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors Grant 9,957,264 - Childers , et al. May 1, 2 | 2018-05-01 |
N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors Grant 9,957,265 - Dinsmore , et al. May 1, 2 | 2018-05-01 |
Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors Grant 9,725,445 - Childers , et al. August 8, 2 | 2017-08-08 |
Cycloalkyl Nitrile Pyrazolo Pyridones As Janus Kinase Inhibitors App 20160280704 - Childers; Matthew Lloyd ;   et al. | 2016-09-29 |
Geminally Substituted Cyanoethylpyrazolo Pyridones As Janus Kinase Inhibitors App 20160272632 - Childers; Matthew Lloyd ;   et al. | 2016-09-22 |
N-(2-cyano Heterocyclyl) Pyrazolo Pyridones As Janus Kinase Inhibitors App 20160272633 - Dinsmore; Christopher ;   et al. | 2016-09-22 |
Acyclic Cyanoethylpyrazolo Pyridones As Janus Kinase Inhibitors App 20160272634 - Dinsmore; Christopher ;   et al. | 2016-09-22 |
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20160235727 - Barr; Kenneth Jay ;   et al. | 2016-08-18 |
CETP Inhibitors App 20160075724 - Ali; Amjad ;   et al. | 2016-03-17 |
Cyclic amine substituted oxazolidinone CETP inhibitor Grant 9,221,834 - Lu , et al. December 29, 2 | 2015-12-29 |
Cetp Inhibitors App 20140221383 - Ali; Amjad ;   et al. | 2014-08-07 |
CETP inhibitors Grant 8,735,435 - Ali , et al. May 27, 2 | 2014-05-27 |
Cyclic Amine Substituted Oxazolidinone CETP Inhibitor App 20130331372 - Lu; Zhijian ;   et al. | 2013-12-12 |
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,604,038 - Edmondson , et al. December 10, 2 | 2013-12-10 |
CETP inhibitors Grant 8,334,290 - Ali , et al. December 18, 2 | 2012-12-18 |
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120225886 - Edmondson; Scott D. ;   et al. | 2012-09-06 |
CETP inhibitors Grant 7,910,592 - Ali , et al. March 22, 2 | 2011-03-22 |
Cetp Inhibitors App 20100249024 - Ali; Amjad ;   et al. | 2010-09-30 |
CETP inhibitors Grant 7,781,426 - Ali , et al. August 24, 2 | 2010-08-24 |
CETP inhibitors Grant 7,737,295 - Ali , et al. June 15, 2 | 2010-06-15 |
Cetp Inhibitors App 20100099716 - ALI; Amjad ;   et al. | 2010-04-22 |
CETP inhibitors Grant 7,652,049 - Ali , et al. January 26, 2 | 2010-01-26 |
1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators Grant 7,625,937 - Ali , et al. December 1, 2 | 2009-12-01 |
Cetp Inhibitors App 20090264405 - Ali; Amjad ;   et al. | 2009-10-22 |
CETP Inhibitors App 20090075979 - Ali; Amjad ;   et al. | 2009-03-19 |
Cetp Inhibitors App 20090042892 - Ali; Amjad ;   et al. | 2009-02-12 |
Selective non-steroidal glucocorticoid receptor modulators Grant 7,411,073 - Ali , et al. August 12, 2 | 2008-08-12 |
Cetp Inhibitors App 20080119476 - Ali; Amjad ;   et al. | 2008-05-22 |
1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators App 20080076795 - Ali; Amjad ;   et al. | 2008-03-27 |
1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators Grant 7,282,591 - Ali , et al. October 16, 2 | 2007-10-16 |
Cetp Inhibitors App 20070225365 - Ali; Amjad ;   et al. | 2007-09-27 |
CETP inhibitors App 20060040999 - Ali; Amjad ;   et al. | 2006-02-23 |
1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators App 20050256315 - Ali, Amjad ;   et al. | 2005-11-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.